It is still unknown whether 10,058-F4, which inhibits the interaction of C-myc/MAX, can indirectly suppress the expression of CIP2A by disrupting the interaction of CIP2A/C-myc in patients with CRC. Here, MYC is linked to colorectal carcinoma.